Literature DB >> 9266455

Is medulloblastoma the same tumor in children and adults?

M T Giordana1, P Cavalla, A Dutto, L Borsotti, A Chiò, D Schiffer.   

Abstract

The appearance of medulloblastoma in adult age and the uncertain overlapping of prognostic factors in pediatric and adult populations stimulate the question of whether medulloblastoma is different in adults and in children. The pathologic features, proliferation potential and glial/neuronal differentiation have been investigated in 42 adult medulloblastomas and 42 medulloblastomas of children; the quantitative data have been compared between the two groups of age. Homer-Wright rosettes, nuclear polymorphism and histologic signs of neuronal differentiation were more frequent in children cases; GFAP-positive tumor cells and desmoplastic type were more frequent in adult cases. The mean, median and rage of Lis, with PCNA and MIB-1 were significantly (p < 0.05) higher in adults than in children. All cases, independently from age of the patients were immunoreactive with markers of neuronal commitment (class III beta tubulin isotype, MAP-2, neurofilaments). The immunoreactivity pattern suggested a more mature neuronal character in desmoplastic cases of adults than of children and in classic cases of children than of adults. In conclusion, some phenotypic differences between childhood and adult medulloblastoma exist, but do not support a substantially different course of the disease. The higher proliferation potential in adult than in childhood cases is unexpected in a tumor of embryonal origin, and reduces the applicability of Collin's law to medulloblastoma.

Entities:  

Mesh:

Year:  1997        PMID: 9266455     DOI: 10.1023/a:1005762727257

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  38 in total

1.  Wilms' tumor: its behavior and prognosis.

Authors:  V P COLLINS
Journal:  J La State Med Soc       Date:  1955-12

2.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.

Authors:  A E Evans; R D Jenkin; R Sposto; J A Ortega; C B Wilson; W Wara; I J Ertel; S Kramer; C H Chang; S L Leikin
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

3.  The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases.

Authors:  H J Bloom; E N Wallace; J M Henk
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1969-01

Review 4.  Medulloblastoma.

Authors:  C D Katsetos; P C Burger
Journal:  Semin Diagn Pathol       Date:  1994-05       Impact factor: 3.464

5.  Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ("arachnoidal sarcoma of the cerebellum").

Authors:  M J Herpers; H Budka
Journal:  Clin Neuropathol       Date:  1985 Jan-Feb       Impact factor: 1.368

6.  Medulloblastoma: freedom from relapse longer than 8 years--a therapeutic cure?

Authors:  M G Belza; S S Donaldson; G K Steinberg; R S Cox; P H Cogen
Journal:  J Neurosurg       Date:  1991-10       Impact factor: 5.115

7.  Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients.

Authors:  C Carrie; C Lasset; C Alapetite; C Haie-Meder; S Hoffstetter; M C Demaille; C Kerr; J P Wagner; J L Lagrange; J P Maire
Journal:  Cancer       Date:  1994-10-15       Impact factor: 6.860

8.  Medulloblastoma in adults: a review of 47 patients treated between 1952 and 1981.

Authors:  H J Bloom; E M Bessell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-04       Impact factor: 7.038

9.  The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950-1981.

Authors:  H J Bloom; J Glees; J Bell; S E Ashley; C Gorman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-04       Impact factor: 7.038

10.  Tumor cell proliferation and apoptosis in medulloblastoma.

Authors:  D Schiffer; P Cavalla; A Chiò; M T Giordana; S Marino; A Mauro; A Migheli
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more
  17 in total

1.  APC mutations in sporadic medulloblastomas.

Authors:  H Huang; B M Mahler-Araujo; A Sankila; L Chimelli; Y Yonekawa; P Kleihues; H Ohgaki
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

Review 2.  Recent advances in embryonal tumours of the central nervous system.

Authors:  Chitra Sarkar; Prabal Deb; Mehar Chand Sharma
Journal:  Childs Nerv Syst       Date:  2005-01-29       Impact factor: 1.475

3.  Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience.

Authors:  A Silvani; P Gaviani; E Lamperti; A Botturi; F Dimeco; A Franzini; P Ferroli; L Fariselli; I Milanesi; A Erbetta; B Pollo; A Salmaggi
Journal:  J Neurooncol       Date:  2011-08-27       Impact factor: 4.130

Review 4.  Nanomedicine as an innovative therapeutic strategy for pediatric cancer.

Authors:  Essa Mohd Aleassa; Malcolm Xing; Richard Keijzer
Journal:  Pediatr Surg Int       Date:  2015-02-18       Impact factor: 1.827

5.  Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index.

Authors:  Chitra Sarkar; Pulakesh Pramanik; Asis Kumar Karak; Partho Mukhopadhyay; Mehar Chand Sharma; Varindera Paul Singh; Veer Singh Mehta
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

6.  Antiangiogenic therapy in the treatment of recurrent medulloblastoma in the adult: case report and review of the literature.

Authors:  Giuseppe Privitera; Grazia Acquaviva; Giovanni Carlo Ettorre; Corrado Spatola
Journal:  J Oncol       Date:  2009-12-30       Impact factor: 4.375

7.  Medulloblastoma in adults. Treatment outcome, relapse patterns, and prognostic factors.

Authors:  S-F Lai; C-W Wang; Y-H Chen; K-H Lan; J C-H Cheng; A-L Cheng; S-H Kuo
Journal:  Strahlenther Onkol       Date:  2012-08-23       Impact factor: 3.621

Review 8.  Management of recurrent medulloblastoma in adult patients: a systematic review and recommendations.

Authors:  Xanthoula Kostaras; Jacob C Easaw
Journal:  J Neurooncol       Date:  2013-07-23       Impact factor: 4.130

9.  MRI of medulloblastoma in adults.

Authors:  S M F Malheiros; H Carrete; J N Stávale; A J Santos; L R R Borges; I F Guimarães; M P Pelaez; C M R Franco; A A Gabbai
Journal:  Neuroradiology       Date:  2003-06-19       Impact factor: 2.804

10.  Tumor Location and Treatment Modality are Associated with Overall Survival in Adult Medulloblastoma.

Authors:  Anthony K Ma; Isaac Freedman; Jun Hui Lee; Danielle Miyagishima; Osama Ahmed; Jacky Yeung
Journal:  Cureus       Date:  2020-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.